179 related articles for article (PubMed ID: 33284639)
21. From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting.
Mumolo MG; Bertani L; Ceccarelli L; Laino G; Di Fluri G; Albano E; Tapete G; Costa F
World J Gastroenterol; 2018 Sep; 24(33):3681-3694. PubMed ID: 30197475
[TBL] [Abstract][Full Text] [Related]
22. [Significance of serum calprotectin in assessing inflammatory bowel disease activity].
Mao JY; Li L; Pang Z
Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(38):3001-3004. PubMed ID: 29061007
[No Abstract] [Full Text] [Related]
23. Calprotectin or Lactoferrin: Do They Help.
Wright EK
Dig Dis; 2016; 34(1-2):98-104. PubMed ID: 26982329
[TBL] [Abstract][Full Text] [Related]
24. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Gray ES; Olson S; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):14-22. PubMed ID: 11479402
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies.
Kim ES; Tarassishin L; Eisele C; Barre A; Nair N; Rendon A; Hawkins K; Debebe A; White S; Thjømøe A; Mørk E; Bento-Miranda M; Panchal H; Agrawal M; Patel A; Chen CL; Kornbluth A; George J; Legnani P; Maser E; Loudon H; Mella MT; Stone J; Dubinsky M; Sabino J; Torres J; Colombel JF; Peter I; Hu J;
Gastroenterology; 2021 Mar; 160(4):1118-1130.e3. PubMed ID: 33307026
[TBL] [Abstract][Full Text] [Related]
26. Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease.
Horvat N; Tavares CC; Andrade AR; Cabral JC; Leao-Filho HM; Caiado AH; Ueda SK; Leite AZ; Sipahi AM; Rocha MS
World J Gastroenterol; 2016 Dec; 22(45):10002-10008. PubMed ID: 28018107
[TBL] [Abstract][Full Text] [Related]
27. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis.
Klingberg E; Strid H; Ståhl A; Deminger A; Carlsten H; Öhman L; Forsblad-d'Elia H
Arthritis Res Ther; 2017 Feb; 19(1):21. PubMed ID: 28148281
[TBL] [Abstract][Full Text] [Related]
28. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
[TBL] [Abstract][Full Text] [Related]
29. The use of fecal calprotectin in monitoring activity of inflammatory bowel diseases.
Knyazev OV; Kagramanova AV; Korneeva IA; Noskova KK; Belousov SV; Parfenov AI
Ter Arkh; 2019 May; 91(4):53-61. PubMed ID: 31094477
[TBL] [Abstract][Full Text] [Related]
30. Serum Calprotectin in Adolescents With Inflammatory Bowel Disease-A Pilot Investigation.
Carlsen K; Malham M; Hansen LF; Petersen JJH; Paerregaard A; Houen G; Wewer V
J Pediatr Gastroenterol Nutr; 2019 May; 68(5):669-675. PubMed ID: 30628981
[TBL] [Abstract][Full Text] [Related]
31. Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease.
Quail MA; Russell RK; Van Limbergen JE; Rogers P; Drummond HE; Wilson DC; Gillett PM
Inflamm Bowel Dis; 2009 May; 15(5):756-9. PubMed ID: 19107785
[TBL] [Abstract][Full Text] [Related]
32. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.
Rokkas T; Portincasa P; Koutroubakis IE
J Gastrointestin Liver Dis; 2018 Sep; 27(3):299-306. PubMed ID: 30240474
[TBL] [Abstract][Full Text] [Related]
33. IBDoc Canadian User Performance Evaluation.
Moore AC; Huang VW; Bourdages R; Fedorak RN; Reinhard C; Leung Y; Bressler B; Rosenfeld G
Inflamm Bowel Dis; 2019 May; 25(6):1107-1114. PubMed ID: 30535387
[TBL] [Abstract][Full Text] [Related]
34. Usability of a home-based test for the measurement of fecal calprotectin in asymptomatic IBD patients.
Bello C; Roseth A; Guardiola J; Reenaers C; Ruiz-Cerulla A; Van Kemseke C; Arajol C; Reinhard C; Seidel L; Louis E
Dig Liver Dis; 2017 Sep; 49(9):991-996. PubMed ID: 28587751
[TBL] [Abstract][Full Text] [Related]
35. Fecal Calprotectin Measured By Patients at Home Using Smartphones--A New Clinical Tool in Monitoring Patients with Inflammatory Bowel Disease.
Vinding KK; Elsberg H; Thorkilgaard T; Belard E; Pedersen N; Elkjaer M; Marker D; Carlsen K; Burisch J; Munkholm P
Inflamm Bowel Dis; 2016 Feb; 22(2):336-44. PubMed ID: 26535869
[TBL] [Abstract][Full Text] [Related]
36. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
Pedersen N
Dan Med J; 2015 Dec; 62(12):B5168. PubMed ID: 26621403
[TBL] [Abstract][Full Text] [Related]
37. Utility of Fecal Calprotectin in Evaluation of Chronic Gastrointestinal Symptoms in Primary Care.
Ramraj R; Garcia A; Mosen D; Waiwaiole L; Smith N
Clin Pediatr (Phila); 2018 Aug; 57(9):1058-1063. PubMed ID: 29192504
[TBL] [Abstract][Full Text] [Related]
38. Fecal Calprotectin Test Performed at Home: A Prospective Study of Pediatric Patients With Inflammatory Bowel Disease.
Piekkala M; Alfthan H; Merras-Salmio L; Puustinen Wikström A; Heiskanen K; Jaakkola T; Klemetti P; Färkkilä M; Kolho KL
J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):926-931. PubMed ID: 29240011
[TBL] [Abstract][Full Text] [Related]
39. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):171-7. PubMed ID: 11321388
[TBL] [Abstract][Full Text] [Related]
40. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
